Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma

P. Sonneveld, E. Asselbergs, S. Zweegman, B. van der Holt, M.J. Kersten, E. Vellenga, M. van Marwijk-Kooy, A. Broyl, O. de Weerdt, S. Lonergan, A. Palumbo, H.M. Lokhorst

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)449-456
Issue number3
Publication statusPublished - 2015

Cite this